Clicky

Fluoguide AS(FLUO)

Description: FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. FluoGuide A/S has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was incorporated in 2018 and is headquartered in Copenhagen, Denmark.


Keywords: Medicine Cancer Clinical Medicine Surgery Clinical Trial Lung Cancer Brain Tumor Brain Cancer Surgical Solutions Treatment Of Lung Cancer High Grade Glioma

Home Page: fluoguide.com

Ole MaalOees Vej 3
Copenhagen, 2200
Denmark
Phone: 45 31 22 66 60


Officers

Name Title
Mr. Morten Albrechtsen B.B.A., M.D., BBA Chief Exec. Officer
Mr. Henrik Hang Chief Financial Officer
Prof. Andreas Kjaer M.D., M.Sc., Ph.D. CSO, CMO, Head of Scientific Advisory Board & Director
Dr. Grethe Nørskov Rasmussen M.Sc., Ph.D. Chief Devel. Officer
Dorthe Gronnegaard Mejer VP of Clinical Devel.

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 8.8612
Price-to-Sales TTM: 348.5461
IPO Date:
Fiscal Year End: December
Full Time Employees: 5
Back to stocks